Literature DB >> 15099629

Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors.

Gerhard Schmidmaier1, Britt Wildemann, Daniel Ostapowicz, Frank Kandziora, Richard Stange, Norbert P Haas, Michael Raschke.   

Abstract

Previous studies showed that growth factors dramatically stimulate healing processes in bone. However, the long-term effect of locally applied growth factors on fracture healing remains unclear. In considering the safety of using growth factors, it is necessary to elucidate that after initial stimulation, the effect stops and the result is a normally healed tissue. Therefore, the purpose of the present study was to investigate the long-term time course of healing processes during growth factor (GF) stimulated and unstimulated fracture healing in a closed tibial fracture model in rats. A well established local drug delivery system was used. IGF-I (50 microg) and TGF-beta 1 (10 microg) were locally applied using a 10 microm thin polylactide (PDLLA) coating on intramedullary implants. The biomechanical and histomorphometrical results demonstrated a significant stimulation of the fracture healing due to the locally applied growth factors compared to control at days 28 and 42 in agreement with the literature. At the last time point, 84 days after fracture, no differences were measurable in the biomechanical testing and the callus composition between the groups. The callus was consistently in the late phase of remodeling with no remaining cartilage. In conclusion, local growth factor application enhances the healing in the early phase without alteration of the normal healing process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099629     DOI: 10.1016/j.orthres.2003.09.009

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  17 in total

1.  The biomechanical and histological effects of platelet-rich plasma on fracture healing.

Authors:  Yunus Guzel; Nazım Karalezli; Onur Bilge; Burkay K Kacira; Hasan Esen; Hakan Karadag; Serdar Toker; Recep Gani Göncü; Mahmut Nedim Doral
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-30       Impact factor: 4.342

2.  Physiology of bone turnover and its application in contemporary maxillofacial surgery. A review.

Authors:  Ch Iliopoulos; L Zouloumis; M Lazaridou
Journal:  Hippokratia       Date:  2010-10       Impact factor: 0.471

3.  Physicochemical and biological characteristics of BMP-2/IGF-1-loaded three-dimensional coaxial electrospun fibrous membranes for bone defect repair.

Authors:  Lihua Yin; Shaohua Yang; Miaomiao He; Yuchen Chang; Kaijuan Wang; Yidan Zhu; Yuhui Liu; Yaoren Chang; Zhanhai Yu
Journal:  J Mater Sci Mater Med       Date:  2017-05-12       Impact factor: 3.896

Review 4.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

5.  Osteopontin functionalization of hydroxyapatite nanoparticles in a PDLLA matrix promotes bone formation.

Authors:  T Jensen; J Baas; A Dolathshahi-Pirouz; T Jacobsen; G Singh; J V Nygaard; M Foss; J Bechtold; C Bünger; F Besenbacher; K Søballe
Journal:  J Biomed Mater Res A       Date:  2011-07-28       Impact factor: 4.396

6.  Synoviocyte-Derived Extracellular Matrix and bFGF Speed Human Chondrocyte Proliferation While Maintaining Differentiation Potential.

Authors:  Rachel D Truong; Megan A Bernier; James E Dennis; Thomas J Kean
Journal:  Front Bioeng Biotechnol       Date:  2022-05-24

7.  Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid.

Authors:  W H Busby; S A Yocum; M Rowland; D Kellner; S Lazerwith; F Sverdrup; M Yates; M Radabaugh; D R Clemmons
Journal:  Osteoarthritis Cartilage       Date:  2008-10-18       Impact factor: 6.576

Review 8.  Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.

Authors:  Arich Ryan Reynolds; Natasha Kyprianou
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 9.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

10.  Characterization of a rat osteotomy model with impaired healing.

Authors:  Christine Kratzel; Camilla Bergmann; Georg Duda; Stefan Greiner; Gerhard Schmidmaier; Britt Wildemann
Journal:  BMC Musculoskelet Disord       Date:  2008-10-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.